|
1
|
Jia X, Liu P, Zhang M, Feng T, Tang H,
Tang Z, Zhao H and Jin T: Genetic variants at 6p21, 10q23, 16q21
and 22q12 are associated with esophageal cancer risk in a Chinese
Han population. Int J Clin Exp Med. 8:19381–19387. 2015.PubMed/NCBI
|
|
2
|
Oze I, Matsuo K, Wakai K, Nagata C, Mizoue
T, Tanaka K, Tsuji I, Sasazuki S, Inoue M and Tsugane S: Research
Group for the Development and Evaluation of Cancer Prevention
Strategies in Japan. Alcohol drinking and esophageal cancer risk:
An evaluation based on a systematic review of epidemiologic
evidence among the Japanese population. Jpn J Clin Oncol.
41:677–692. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Short MW, Burgers KG and Fry VT:
Esophageal cancer. Am Fam Physician. 95:22–28. 2017.PubMed/NCBI
|
|
4
|
Yang C, Shen S, Zheng X, Ye K, Sun Y, Lu Y
and Ge H: Long noncoding RNA HAGLR acts as a microRNA-143-5p sponge
to regulate epithelial-mesenchymal transition and metastatic
potential in esophageal cancer by regulating LAMP3. FASEB J.
33:10490–10504. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lowery AJ, Miller N, McNeill RE and Kerin
MJ: MicroRNAs as prognostic indicators and therapeutic targets:
Potential effect on breast cancer management. Clin Cancer Res.
14:360–365. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Guo L and Lu Z: The fate of miRNA* strand
through evolutionary analysis: Implication for degradation as
merely carrier strand or potential regulatory molecule? PLoS One.
5(e11387)2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Du G, Zhou J, Cheng L, Ma X, Gui Y and Tan
B: High expression of miR-206 predicts adverse outcomes: A
potential therapeutic target for esophageal cancer. Comb Chem High
Throughput Screen. 22:599–611. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang L, Zhang Z, Yu X, Li Q, Wang Q, Chang
A, Huang X, Han X, Song Y, Hu J, et al: SOX9/miR-203a axis drives
PI3K/AKT signaling to promote esophageal cancer progression. Cancer
Lett. 468:14–26. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang L, Chen J, Wang L, Chen L, Du Z, Zhu
L, Cui M, Zhang M and Song L: Linc-PINT acted as a tumor suppressor
by sponging miR-543 and miR-576-5p in esophageal cancer. J Cell
Biochem. 120:19345–19357. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chava S, Reynolds CP, Pathania AS,
Gorantla S, Poluektova LY, Coulter DW, Gupta SC, Pandey MK and
Challagundla KB: MiR-15a-5p, miR-15b-5p, and miR-16-5p inhibit
tumor progression by directly targeting MYCN in neuroblastoma. Mol
Oncol. 14:180–196. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Marcuello M, Duran-Sanchon S, Moreno L,
Lozano JJ, Bujanda L, Castells A and Gironella M: Analysis of A
6-Mirna signature in serum from colorectal cancer screening
participants as non-invasive biomarkers for advanced adenoma and
colorectal cancer detection. Cancers (Basel).
11(1542)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yuan C, Zhang Y, Tu W and Guo Y:
Integrated miRNA profiling and bioinformatics analyses reveal
upregulated miRNAs in gastric cancer. Oncol Lett. 18:1979–1988.
2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wang L, Yu X, Zhang Z, Pang L, Xu J, Jiang
J, Liang W, Chai Y, Hou J and Li F: Linc-ROR promotes esophageal
squamous cell carcinoma progression through the derepression of
SOX9. J Exp Clin Cancer Res. 36(182)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li CY, Zhang WW, Xiang JL, Wang XH, Li J
and Wang JL: Identification of microRNAs as novel biomarkers for
esophageal squamous cell carcinoma: A study based on the cancer
genome atlas (TCGA) and bioinformatics. Chin Med J (Engl).
132:2213–2222. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu Z, Chen M, Xie LK, Liu T, Zou ZW, Li
Y, Chen P, Peng X, Ma C, Zhang WJ and Li PD: CLCA4 inhibits cell
proliferation and invasion of hepatocellular carcinoma by
suppressing epithelial-mesenchymal transition via PI3K/AKT
signaling. Aging (Albany NY). 10:2570–2584. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang J, Zhang L, Jiang Z, Ge C, Zhao F,
Jiang J, Tian H, Chen T, Xie H, Cui Y, et al: TCF12 promotes the
tumorigenesis and metastasis of hepatocellular carcinoma via
upregulation of CXCR4 expression. Theranostics. 9:5810–5827.
2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang F, Li K, Yao X, Wang H, Li W, Wu J,
Li M, Zhou R, Xu L and Zhao L: A miR-567-PIK3AP1-PI3K/AKT-c-Myc
feedback loop regulates tumour growth and chemoresistance in
gastric cancer. EBioMedicine. 44:311–321. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sheng J, Deng X, Zhang Q, Liu H, Wang N,
Liu Z, Dai E and Deng Q: PAR-2 promotes invasion and migration of
esophageal cancer cells by activating MEK/ERK and PI3K/Akt
signaling pathway. Int J Clin Exp Pathol. 12:787–797.
2019.PubMed/NCBI
|
|
21
|
Song Y, Liu H, Cui C, Peng X, Wang C, Tian
X and Li W: Silencing of peroxiredoxin 1 inhibits the proliferation
of esophageal cancer cells and promotes apoptosis by inhibiting the
activity of the PI3K/AKT pathway. Cancer Manag Res. 11:10883–10890.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang J, Zhou Y, Jiang K, Shen Z, Ye Y and
Wang S: Evaluation of the seventh AJCC TNM staging system for
gastric cancer: A meta-analysis of cohort studies. Tumour Biol.
35:8525–8532. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shimada A, Tsushima T, Tsubosa Y, Booka E,
Takebayashi K, Niihara M, Isaka M, Ohde Y, Machida N, Onozawa Y, et
al: Validity of surgical resection for lymph node or pulmonary
recurrence of esophageal cancer after definitive treatment. World J
Surg. 43:1286–1293. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Steffen T, Dietrich D, Schnider A,
Kettelhack C, Huber O, Marti WR, Furrer M, Gloor B, Schiesser M,
Thierstein S, et al: Recurrence patterns and long-term results
after induction chemotherapy, chemoradiotherapy, and curative
surgery in patients with locally advanced esophageal cancer. Ann
Surg. 269:83–87. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Matos B, Bostjancic E, Matjasic A, Popovic
M and Glavac D: Dynamic expression of 11 miRNAs in 83 consecutive
primary and corresponding recurrent glioblastoma: Correlation to
treatment, time to recurrence, overall survival and MGMT
methylation status. Radiol Oncol. 52:422–432. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wen F, Xu JZ and Wang XR: Increased
expression of miR-15b is associated with clinicopathological
features and poor prognosis in cervical carcinoma. Arch Gynecol
Obstet. 295:743–749. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu Z, Hu G, Zhao Y, Xiao Z, Yan M and Ren
M: Silence of cZNF292 suppresses the growth, migration, and
invasion of human esophageal cancer Eca-109 cells via upregulating
miR-206. J Cell Biochem. 121:2354–2362. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lovat F, Fassan M, Sacchi D, Ranganathan
P, Palamarchuk A, Bill M, Karunasiri M, Gasparini P, Nigita G,
Distefano R, et al: Knockout of both miR-15/16 loci induces acute
myeloid leukemia. Proc Natl Acad Sci USA. 115:13069–13074.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gottmann P, Ouni M, Saussenthaler S, Roos
J, Stirm L, Jähnert M, Kamitz A, Hallahan N, Jonas W, Fritsche A,
et al: A computational biology approach of a genome-wide screen
connected miRNAs to obesity and type 2 diabetes. Mol Metab.
11:145–159. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang J, Liu H, Tian L, Wang F, Han L,
Zhang W and Bai YA: MiR-15b inhibits the progression of
glioblastoma cells through targeting insulin-like growth factor
receptor 1. Horm Cancer. 8:49–57. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Weng Y, Shen Y, He Y, Pan X, Xu J, Jiang
Y, Zhang Q, Wang S, Kong F, Zhao S, et al: The miR-15b-5p/PDK4 axis
regulates osteosarcoma proliferation through modulation of the
Warburg effect. Biochem Biophys Res Commun. 503:2749–2757.
2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Xin QL, Deng CL, Chen X, Wang J, Wang SB,
Wang W, Deng F, Zhang B, Xiao G and Zhang LK: Quantitative
proteomic analysis of mosquito C6/36 cells reveals host proteins
involved in Zika virus infection. J Virol. 91:e00554–17.
2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lu Z, Wu Z, Hu J, Wei W, Ma B and Wen D:
MicroRNA-15 regulates the proliferation, migration and invasion of
thyroid cancer cells by targeting Bcl-2. J BUON. 24:2114–2119.
2019.PubMed/NCBI
|
|
35
|
Lu L, Li Y, Wen H and Feng C:
Overexpression of miR-15b promotes resistance to sunitinib in renal
cell carcinoma. J Cancer. 10:3389–3396. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Pan WY, Zeng JH, Wen DY, Wang JY, Wang PP,
Chen G and Feng ZB: Oncogenic value of microRNA-15b-5p in
hepatocellular carcinoma and a bioinformatics investigation. Oncol
Lett. 17:1695–1713. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Shi N, Yu H and Chen T: Inhibition of
esophageal cancer growth through the suppression of PI3K/AKT/mTOR
signaling pathway. Onco Targets Ther. 12:7637–7647. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yang SX, Polley E and Lipkowitz S: New
insights on PI3K/AKT pathway alterations and clinical outcomes in
breast cancer. Cancer Treat Rev. 45:87–96. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Janku F, Yap TA and Meric-Bernstam F:
Targeting the PI3K pathway in cancer: Are we making headway? Nat
Rev Clin Oncol. 15:273–291. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zheng TL, Li DP, He ZF and Zhao S: miR-145
sensitizes esophageal squamous cell carcinoma to cisplatin through
directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int.
19(250)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lin C, Liu A, Zhu J, Zhang X, Wu G, Ren P,
Wu J, Li M, Li J and Song L: miR-508 sustains phosphoinositide
signalling and promotes aggressive phenotype of oesophageal
squamous cell carcinoma. Nat Commun. 5(4620)2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Pan F, Mao H, Bu F, Tong X, Li J, Zhang S,
Liu X, Wang L, Wu L, Chen R, et al: Sp1-mediated transcriptional
activation of miR-205 promotes radioresistance in esophageal
squamous cell carcinoma. Oncotarget. 8:5735–5752. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Li GC, Qin XL, Song HH, Li YN, Qiu YY, Cui
SC, Wang YS, Wang H and Gong JL: Upregulated microRNA-15b
alleviates ovarian cancer through inhitbition of the PI3K/Akt
pathway by targeting LPAR3. J Cell Physiol. 234:22331–22342.
2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Sun Y, Gao Y, Song T, Yu C, Nie Z and Wang
X: MicroRNA-15b participates in the development of peripheral
arterial disease by modulating the growth of vascular smooth muscle
cells. Exp Ther Med. 18:77–84. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Park J, Feng J, Li Y, Hammarsten O, Brazil
DP and Hemmings BA: DNA-dependent protein kinase-mediated
phosphorylation of protein kinase B requires a specific recognition
sequence in the C-terminal hydrophobic motif. J Biol Chem.
284:6169–6174. 2009.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Szymonowicz K, Oeck S, Malewicz NM and
Jendrossek V: New insights into protein kinase B/Akt signaling:
Role of localized Akt activation and compartment-specific target
proteins for the cellular radiation response. Cancers (Basel).
10(78)2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Porta C, Paglino C and Mosca A: Targeting
PI3K/Akt/mTOR Signaling in cancer. Front Oncol.
4(64)2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hu H, Wang F, Wang M, Liu Y, Wu H, Chen X
and Lin Q: FAM83A is amplified and promotes tumorigenicity in
non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways. Int
J Med Sci. 17:807–814. 2020.PubMed/NCBI View Article : Google Scholar
|
